Evidence map›Paper›PMID 39360946›Full record

ArticleJournal of chemical information and modeling2024

Modeling Protein-Glycan Interactions with HADDOCK.

Anna Ranaudo, Marco Giulini, Angela Pelissou Ayuso, Alexandre M J J Bonvin

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna RanaudoDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza Della Scienza 1, Milan 20126, Italy.ORCID 0000-0002-8733-7938
Marco GiuliniBijvoet Centre for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, Utrecht 3584CH, The Netherlands.
Angela Pelissou AyusoBijvoet Centre for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, Utrecht 3584CH, The Netherlands.
Alexandre M J J BonvinBijvoet Centre for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, Padualaan 8, Utrecht 3584CH, The Netherlands.ORCID 0000-0001-7369-1322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term glycan refers to a broad category of molecules composed of monosaccharide units linked to each other in a variety of ways, whose structural diversity is related to different functions in living organisms. Among others, glycans are recognized by proteins with the aim of carrying information and for signaling purposes. Determining the three-dimensional structures of protein-glycan complexes is essential both for the understanding of the mechanisms glycans are involved in and for applications such as drug design. In this context, molecular docking approaches are of undoubted importance as complementary approaches to experiments. In this study, we show how high ambiguity-driven DOCKing (HADDOCK) can be efficiently used for the prediction of protein-glycan complexes. Using a benchmark of 89 complexes, starting from their bound or unbound forms, and assuming some knowledge of the binding site on the protein, our protocol reaches a 70% and 40% top 5 success rate on bound and unbound data sets, respectively. We show that the main limiting factor is related to the complexity of the glycan to be modeled and the associated conformational flexibility.

Indexed as

Molecular Docking SimulationPolysaccharidesProteinsBinding SitesProtein BindingProtein ConformationPolysaccharidesProteins

Identifiers

PMID39360946
PMCPMC11480977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.